Evidence map›Paper›PMID 25739496›Full record

ArticleCancer2015

Cancer stage at diagnosis in patients infected with the human immunodeficiency virus and transplant recipients.

Meredith S Shiels, Glenn Copeland, Marc T Goodman, Janna Harrell, Charles F Lynch, Karen Pawlish, Ruth M Pfeiffer, Eric A Engels

Abstract read
In one paragraph

Article in Cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 3 pooled it
3.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 3 syntheses or guidelines pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Risk of Skin Cancers in Older Persons Living With HIV: A Systematic Review.The Journal of the Association of Nurses in AIDS Care : JANAC
    Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Outcomes in solid organ transplant recipients with a pretransplant diagnosis of melanoma.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2024
    Article
  17. Brief Report: The Virome of Bladder Tumors Arising in People Living With HIV.Journal of acquired immune deficiency syndromes (1999) · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 1 country.

Meredith S ShielsDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.
Glenn CopelandMichigan Cancer Surveillance Program, Michigan Department of Community Health, Lansing, Michigan.
Marc T GoodmanSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
Janna HarrellUtah Cancer Registry, Salt Lake City, Utah.
Charles F LynchDepartment of Epidemiology, College of Public Health, The University of Iowa, Iowa City, Iowa.
Karen PawlishNew Jersey State Cancer Registry, New Jersey Department of Health, Trenton, New Jersey.
Ruth M PfeifferDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.
Eric A EngelsDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.
National Cancer Institute · USCedars-Sinai Medical Center · USDivision of Cancer Epidemiology and GeneticsMichigan Department of Health and Human Services · USNew Jersey Department of Health · USUniversity of Iowa · USUtah Cancer Specialists · US

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Douglas Robert Spitz · 2000 to 2026
$70.0M
NATIONAL CANCER PREVENTION AND CONTROL PROGRAMU58DP000824 · DP · TEXAS STATE DEPT OF HEALTH SERVICES · PI DELGADO, EVELYN · 2007 to 2011
$44.3M
NEW YORK STATE CANCER PREVENTION & CONTROL PROGRAMU58DP003879 · DP · NYSDOH/HEALTH RESEARCH, INC. · PI WALLACE, BARBARA J · 2012 to 2014
$37.6M
MICHIGAN CANCER PREVENTION & CONTROL PROGRAMU58DP003921 · DP · MICHIGAN STATE DEPARTMENT OF HEALTH AND HUMAN SERVICES · PI BROOKOVER, PATRICIA · 2012 to 2014
$30.7M
Category A - Communities Putting Prevention to WorkU58DP000848 · DP · COLORADO STATE DEPT/PUB HLTH & ENVIRONMT · PI JACOBELLIS, JILLIAN · 2007 to 2011
$25.9M
Infections, immunity, and inflammation in cancerZIACP010150 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ENGELS, ERIC A · 2009 to 2025
$24.0M
NATIONAL CANCER PREVENTION AND CONTROL PROGRAMU58DP000832 · DP · NC STATE DEPT/HLTH & HUMAN SERVICES · PI PETERSEN, RUTH · 2007 to 2011
$23.6M
NATIONAL CANCER PREVENTION & CONTROL PROGRAM - ILLINOISU58DP003883 · DP · ILLINOIS STATE DEPT OF PUBLIC HEALTH · PI MOODY, CONNY · 2012 to 2014
$22.6M
CALIFORNIA'S PARTICIPATION IN THE NATIONAL CANCER PREVENTION AND CONTRO PROGRAMU58DP000807 · DP · PUBLIC HEALTH INSTITUTE · PI SNIPES, KURT P · 2007 to 2011
$22.5M
GEORGIA COMPREHENSIVE CANCER CONTROL PROGRAMU58DP003875 · DP · GEORGIA DIVISION OF PUBLIC HEALTH · PI O'CONNOR, JEAN CATHERINE · 2012 to 2014
$15.9M
NEW JERSEY CANCER PREVENTION & CONTROL PROGRAMU58DP003931 · DP · NEW JERSEY STATE DEPT/HEALTH/SENIOR SRVS · PI RODRIQUEZ, GLORIA · 2012 to 2014
$11.9M
MASSACHUSETTS CANCER PREVENTION & CONTROL PROGRAMU58DP003920 · DP · MASSACHUSETTS STATE DEPT OF PUB HEALTH · PI NYAMBOSE, JOSHUA · 2012 to 2014
$11.4M
Intramural NIH HHS Z99 CA999999NCCDPHP CDC HHS 1U58 DP000807-01NCCDPHP CDC HHS 5458DP003920NCCDPHP CDC HHS 5U58DP000824-04NCCDPHP CDC HHS 5U58DP003875-01NCCDPHP CDC HHS 5U58DP003883-03NCCDPHP CDC HHS 5U58DP003921-03NCCDPHP CDC HHS 5U58/DP003931-02NCCDPHP CDC HHS U58 DP000807NCCDPHP CDC HHS U58 DP000824NCCDPHP CDC HHS U58 DP000832NCCDPHP CDC HHS U58DP000832NCCDPHP CDC HHS U58 DP000848NCCDPHP CDC HHS U58 DP000848-04NCCDPHP CDC HHS U58 DP003875NCCDPHP CDC HHS U58 DP003879NCCDPHP CDC HHS U58DP003879NCCDPHP CDC HHS U58 DP003883NCCDPHP CDC HHS U58 DP003920NCCDPHP CDC HHS U58 DP003921NCCDPHP CDC HHS U58 DP003931NCCDPHP CDC HHS U58DP12-1205 3919-03NCHHSTP CDC HHS 5U62PS001005-0NCHHSTP CDC HHS 5U62PS004011-02NCHHSTP CDC HHS 5U62PS004015NCHHSTP CDC HHS U62 PS001005NCHHSTP CDC HHS U62 PS004001NCHHSTP CDC HHS U62PS004001-2NCHHSTP CDC HHS U62 PS004011NCHHSTP CDC HHS U62 PS004015NCI NIH HHS HHSN261201000024CNCI NIH HHS HHSN261201000026CNCI NIH HHS HHSN261201000034CNCI NIH HHS HHSN261201000035CNCI NIH HHS HHSN261201000035INCI NIH HHS HHSN261201000036CNCI NIH HHS HHSN261201000037CNCI NIH HHS HHSN261201300021CNCI NIH HHS N01 PC035137NCI NIH HHS N01 PC035139NCI NIH HHS N01 PC035142NCI NIH HHS N01 PC035143NCI NIH HHS N01-PC-2013-00021NCI NIH HHS N01-PC-35137NCI NIH HHS N01-PC-35139NCI NIH HHS N01-PC-35142NCI NIH HHS N01-PC-35143
6 · The paper itself

Abstract

backgroundIt is unknown whether immunosuppression results in more aggressive, advanced stage cancers. Because cancer stage is influenced both by tumor biology and medical surveillance, the authors assessed cancer stage in individuals infected with the human immunodeficiency virus (HIV) and solid organ transplant recipients, 2 immunosuppressed groups with differences in their health care use.

methodsThe authors used data on all cases of 15 cancer types diagnosed during 1996 through 2010 in 2 studies that linked US cancer registries with HIV and transplant registries. Odds ratios (ORs) for advanced (vs local) disease were estimated comparing HIV and transplant populations with immunocompetent individuals in polytomous logistic regression models adjusted for age, sex, race, registry, and year.

resultsA total of 8411 of 4.5 million cancer cases occurred in HIV-infected individuals and 7322 of 6.4 million cancer cases occurred in transplant recipients. Compared with immunocompetent patients with cancer, those infected with HIV were more likely to be diagnosed with distant stage lung (OR, 1.13), female breast (OR, 1.99), and prostate (OR, 1.57) cancers, whereas transplant recipients had fewer distant stage lung (OR, 0.54), female breast (OR, 0.75), and prostate (OR, 0.72) cancers. Both immunosuppressed populations had a shift toward advanced stage melanoma (ORs of 1.97 for HIV-infected individuals and 1.82 for transplant recipients) and bladder cancer (ORs of 1.42 for HIV-infected individuals and 1.54 for transplant recipients).

conclusionsBladder cancer and melanoma were more likely to be diagnosed at a nonlocal stage in both HIV-infected individuals and transplant recipients, suggesting a role for immunosuppression in their progression. In addition, we observed a shift for some common cancers toward later stages in HIV-infected individuals and toward earlier stages in transplant recipients, which is consistent with differential access to medical care or surveillance.

Indexed as

Transplant RecipientsAdultAgedFemaleHIV InfectionsHumansImmunosuppression TherapyIncidenceMaleMiddle AgedNeoplasmsNeoplasm StagingTransplantation ImmunologyYoung Adultcancerhuman immunodeficiency virus (HIV)stagetransplant

Identifiers

PMID25739496
PMCPMC4470321
OpenAlexW1504985344

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.